Pluri Inc. (PLUR) stock
PLURNasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends June 30
$1.05−0.04 (-3.67%)
Close on Nov 13, 2026Market cap $12.96MP/E –Yield –
Pluri operating margin
Operating margin is operating income as a percentage of revenue.
Pluri's operating margin for the twelve months ending Sep 30, 2026 was -2341.1%. For fiscal 2026 it was -2454.5%, against -1659.9% the year before. The highest annual figure on record is -819.1% in fiscal 2016.
Annual operating margin
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| FY2026 | Jun 30, 2026 | -2454.5% | −794.6 |
| FY2025 | Jun 30, 2025 | -1659.9% | +5137.1 |
| FY2024 | Jun 30, 2024 | -6796.9% | +2696.4 |
| FY2023 | Jun 30, 2023 | -9493.4% | +8281.4 |
| FY2022 | Jun 30, 2022 | -17774.8% | +110381.7 |
| FY2020 | Jun 30, 2020 | -128156.5% | −62356.5 |
| FY2019 | Jun 30, 2019 | -65800.0% | +1662.0 |
| FY2018 | Jun 30, 2018 | -67462.0% | −66642.9 |
| FY2016 | Jun 30, 2016 | -819.1% | +5847.7 |
| FY2015 | Jun 30, 2015 | -6666.8% | +681.5 |
| FY2014 | Jun 30, 2014 | -7348.3% | −4075.4 |
| FY2013 | Jun 30, 2013 | -3272.9% | −1173.6 |
| FY2012 | Jun 30, 2012 | -2099.3% | – |
Quarterly operating margin
Change is against the same quarter a year earlier.
Periods
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| Q1 FY2027CQ3 2026 | Sep 30, 2026 | -2051.3% | −41.8 |
| Q4 FY2026CQ2 2026 | Jun 30, 2026 | -1655.5% | +8.0 |
| Q3 FY2026CQ1 2026 | Mar 31, 2026 | -3913.8% | −2649.1 |
| Q2 FY2026CQ4 2025 | Dec 31, 2025 | -3285.9% | −606.4 |
| Q1 FY2026CQ3 2025 | Sep 30, 2025 | -2009.5% | −415.0 |
| Q4 FY2025CQ2 2025 | Jun 30, 2025 | -1663.6% | +4621.8 |
| Q3 FY2025CQ1 2025 | Mar 31, 2025 | -1264.6% | +6529.7 |
| Q2 FY2025CQ4 2024 | Dec 31, 2024 | -2679.5% | +2285.3 |
| Q1 FY2025CQ3 2024 | Sep 30, 2024 | -1594.5% | +8362.9 |
| Q4 FY2024CQ2 2024 | Jun 30, 2024 | -6285.4% | −389.9 |
| Q3 FY2024CQ1 2024 | Mar 31, 2024 | -7794.4% | +366.6 |
| Q2 FY2024CQ4 2023 | Dec 31, 2023 | -4964.8% | +328985.2 |
| Q1 FY2024CQ3 2023 | Sep 30, 2023 | -9957.4% | −1999.9 |
| Q4 FY2023CQ2 2023 | Jun 30, 2023 | -5895.5% | −1419.0 |
| Q3 FY2023CQ1 2023 | Mar 31, 2023 | -8160.9% | +19526.0 |
| Q2 FY2023CQ4 2022 | Dec 31, 2022 | -333950.0% | −317288.0 |
| Q1 FY2023CQ3 2022 | Sep 30, 2022 | -7957.5% | +216292.5 |
| Q3 FY2022CQ1 2022 | Mar 31, 2022 | -4476.5% | +12457.5 |
| Q2 FY2020CQ4 2019 | Dec 31, 2019 | -27687.0% | – |
| Q2 FY2019CQ4 2018 | Dec 31, 2018 | -16662.0% | – |
| Q1 FY2019CQ3 2018 | Sep 30, 2018 | -224250.0% | – |
| Q2 FY2018CQ4 2017 | Dec 31, 2017 | -16934.0% | – |
See a number that looks wrong?